AVCRFPharmaceutical PreparationsFiscal year ends December 31
Avricore Health Inc.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 16, 2025
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
Share price
−$0.0663 (−98.81%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Avricore Health Inc. grew revenue 33.7% to C$4.66M over fiscal 2024. Free cash flow was C$823.52K.
Revenue
C$4.66M
+33.7% vs. a year earlier
Free cash flow
C$823.52K
FY2024
EPS, diluted
-0.01 CAD
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Dec 31, 2024
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$4.66M
- EPS, diluted
- -0.01 CAD
- Free cash flow
- C$823.52K
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Ten years at a glance
Fiscal years 2014 to 2024, CAD
Revenue
C$4.66M+33.7% YoY
Gross profit
C$1.88M+56.2% YoY
Net income
–
EPS, diluted
-0.01 CAD
Free cash flow
C$823.52K
Reported period